FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 333:1574 December 7, 1995 Number 23 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited

Edited by Christian L. Shriqui and Henry A. Nasrallah. 863 pp. Washington, D.C., American Psychiatric Press, 1995. $95. ISBN 0-88048-681-3.

Schizophrenia is a most interesting and vexing disease. Its prevalence is high (0.85 percent), its economic impact is severe, and the disease processes undermine a myriad of brain functions, causing distinctively human impairments. Patients have altered perception, false beliefs, disturbance of thought, and often remarkably reduced drive, inability to initiate action, and restriction in emotional experience and expression. Illness usually begins early in life and is long-lasting. The cause, cure, and prevention of schizophrenia are not yet understood, but there have been substantial advances in comprehending and treating this illness. Recent developments involving new antipsychotic medications, empirically validated psychosocial treatment, . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.